:

Mei Zhan1,2, Qinran Long1,2, Jinhan He1,2,3

  • 1Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China.

PubMed
概括

免疫检查点抑制剂 (ICI) 治疗很少会导致胰腺不良事件 (AE). 胰腺癌,肺癌,年轻年龄和PD-L1抑制剂与严重ICI诱导的胰腺AEs的风险更高有关.